Is the price fair?
What USPH's price assumes
Today's price asks for 2.0% free cash flow growth a year; over the last three years U.S. Physical Therapy, Inc. delivered 9.7%, less than the record.
1.42
Price / sales · no P/E: the last twelve months did not end in a profit
- Free cash flow yield
- 6.6%
Free cash flow yield · Medical Care Facilities median 7.8%
- Growth the price implies
- +2.0%
Growth the price implies · The price pays for +2.0% free cash flow growth a year for a decade; the business has delivered +9.7% a year over the last three.
- Price / book
- 2.41
Price / book · as of 2026-Q1
Details›
- Price / book2026-Q1
- 2.41
- EV / EBIT2026-Q1
- 16.3
- EV / sales2026-Q1
- 1.63
- Free cash flow, trailing twelve months
- $67M
- Market capitalisation
- $1.01B
- 3-year revenue growth
- +12%
- 3-year free cash flow growth
- +9.7%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $18.47 |
| Its own P/E history, median | $20.62 |
| Its own P/E history, upper quartile | $29.97 |
| 52-week range | $58.57 – $91.35 |
| Today | $78.30 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Care Facilities
The closest names by size in the same industry